06 February 2020 House Ways and Means hearing on overcoming pharmaceutical barriers to cures explores tax treatment of pharmaceutical companies, among other practices On February 5, the House Ways and Means Committee held a hearing titled "More Cures for More Patients: Overcoming Pharmaceutical Barriers," featuring testimony from patient advocates, academia and the medical community. In opening the hearing, Subcommittee Chairman Lloyd Doggett (D-TX) first criticized President Trump's drug pricing remarks at the State of the Union, saying that in reality the administration has done little to address the issue of drug prices and that they have continued to increase, noting that the committee will work to reduce costs and bring new cures by exploring necessary market reforms. In contrast, Subcommittee Ranking Member Devin Nunes (R-CA) panned the Democratic drug pricing bill, H.R. 3, which he said would reduce cures, and urged the committee to take up bipartisan solutions such as those offered in the Republican alternative bill, H.R. 19.
Document ID: 2020-0313 | |||||
